Rxivist logo

Comparative profiling of the synaptic proteome from Alzheimer's disease patients with focus on the APOE genotype

By Raphael Hesse, Maica Llavero Hurtado, Rosemary J. Jackson, Samantha L Eaton, Abigail G Herrmann, Marti Colom-Cadena, Declan King, Jamie Rose, Jane Tulloch, Chris-Anne McKenzie, Colin Smith, Christopher Henstridge, Douglas Lamont, Thomas M. Wishart, Tara L Spires-Jones

Posted 08 May 2019
bioRxiv DOI: 10.1101/631556 (published DOI: 10.1186/s40478-019-0847-7)

Degeneration of synapses in Alzheimer's disease (AD) strongly correlates with cognitive decline, and synaptic pathology contributes to disease pathophysiology. We recently discovered that the strongest genetic risk factor for sporadic AD, apolipoprotein E epsilon 4 (APOE4), exacerbates synapse loss and synaptic accumulation of oligomeric amyloid beta in human AD brain. To begin to understand the molecular cascades involved in synapse loss in AD and how this is mediated by APOE, and to generate a resource of knowledge of changes in the synaptic proteome in AD, we conducted a proteomic screen and systematic in-silico analysis of synaptoneurosome preparations from temporal and occipital cortices of human AD and control subjects with known APOE gene status. Our analysis identified over 5,500 proteins in human synaptoneurosomes and highlighted disease, brain region, and APOE-associated changes in multiple molecular pathways including a decreased abundance in AD of proteins important for synaptic and mitochondrial function and an increased abundance of proteins involved in neuroimmune interactions and intracellular signaling.

Download data

  • Downloaded 766 times
  • Download rankings, all-time:
    • Site-wide: 38,761
    • In neuroscience: 5,197
  • Year to date:
    • Site-wide: 126,280
  • Since beginning of last month:
    • Site-wide: 135,449

Altmetric data

Downloads over time

Distribution of downloads per paper, site-wide